Alterations in intracellular calcium transients of fibroblasts from progressive systemic sclerotic patients: a digital imaging microscopic study
- PMID: 2069418
- DOI: 10.1007/BF00371616
Alterations in intracellular calcium transients of fibroblasts from progressive systemic sclerotic patients: a digital imaging microscopic study
Abstract
Intracellular Ca2+ concentrations ([Ca2+]i) in cultured skin fibroblasts from normal subjects and progressive systemic sclerosis (PSS) patients were determined by using Fura-2 and fluorescent videomicroscopy. With the exception of fibroblasts from one PSS patient showing a higher [Ca2+]i, no significant difference was observed in resting [Ca2+]i between the two groups of fibroblasts. Bradykinin (BK) (10 microM) induced a transient [Ca2+]i increase in normal fibroblasts, whereas the BK-induced [Ca2+]i increase was reduced or not detectable in PSS fibroblasts. Removal of extracellular Ca2+ did not eliminate the BK-induced [Ca2+]i increase in normal fibroblasts. These findings suggest that BK stimulates Ca2+ release from intracellular stores in human fibroblasts, and also that the BK-mediated Ca2+ release is impaired in PSS fibroblasts.
Similar articles
-
Decreased bradykinin binding sites in fibroblasts from progressive systemic scleroderma.Arch Dermatol Res. 1994;286(3-4):133-6. doi: 10.1007/BF00374207. Arch Dermatol Res. 1994. PMID: 8002664
-
Bradykinin-induced Ca2+ entry, release, and refilling of intracellular Ca2+ stores. Relationships revealed by image analysis of individual human fibroblasts.J Biol Chem. 1992 Jan 5;267(1):108-18. J Biol Chem. 1992. PMID: 1730576
-
Defective formation of inositol 1,4,5-trisphosphate in bradykinin-stimulated fibroblasts from progressive systemic sclerotic patients.Biochem Biophys Res Commun. 1988 Nov 15;156(3):1077-82. doi: 10.1016/s0006-291x(88)80742-3. Biochem Biophys Res Commun. 1988. PMID: 3263854
-
Bradykinin induces a B2 receptor-mediated calcium signal linked to prostanoid formation in human gingival fibroblasts in vitro.Agents Actions. 1992 Sep;37(1-2):44-52. doi: 10.1007/BF01987889. Agents Actions. 1992. PMID: 1333726
-
Fibroblast models of neurological disorders: fluorescence measurement studies.Trends Pharmacol Sci. 1998 May;19(5):171-7. doi: 10.1016/s0165-6147(98)01202-4. Trends Pharmacol Sci. 1998. PMID: 9652189 Review.
Cited by
-
Targeting CD13/Aminopeptidase N as a Novel Therapeutic Approach for Scleroderma Fibrosis.Arthritis Rheumatol. 2025 Jan;77(1):80-91. doi: 10.1002/art.42973. Epub 2024 Sep 18. Arthritis Rheumatol. 2025. PMID: 39175116 Free PMC article.
-
Decreased bradykinin binding sites in fibroblasts from progressive systemic scleroderma.Arch Dermatol Res. 1994;286(3-4):133-6. doi: 10.1007/BF00374207. Arch Dermatol Res. 1994. PMID: 8002664
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous